Company Leadership

Company Leadership

Douglas G. Cave Ph.D, MPH, President & Founder

Doug Cave is the founder of CCGroup, and oversees all aspects of the company’s operations, development and sales. Doug has served as CEO, President and COO of several healthcare companies. He has over 30 years of experience in the HMO, health insurance, pharmacy and physician-hospital organization industries, as well as over 20 years experience in consulting to these industries. He has also been involved in the large employer, employer coalition, TPA, utilization management, and disease management markets, and has published over 100 articles in academic and trade journals and performed numerous speaking engagements at healthcare and trade association meetings. Doug holds a Ph.D in Health Policy and Planning, as well as a Masters’ of Public Health in Infectious Disease Epidemiology.

    Yuri Alexandrian, Chief Operating Officer and Chief Information Officer

    Yuri Alexandrian is responsible for CCGroup’s Product Development and Technology organizations and Operations team, including Account Management and Client Support. He is a seasoned healthcare technology leader with over 20 years of diverse healthcare and IT experience. Previously, he was a Vice President of Operations and Development at Fortune 16 McKesson Corporation, a leading healthcare company where he directed many enterprise-wide IT and eBusiness initiatives. Yuri obtained his MBA from Santa Clara University and his BS degree in Computer Engineering from California Polytechnic State University, San Luis Obispo.

    John T. Calvin, Vice President of Clinical Systems

    John Calvin directs CCGroup’s Product Development team and is responsible for all software lifecycles including development, maintenance, and testing. He has over 12 years of experience in the healthcare and biosciences arenas. He was previously the Director of Software Development at Iconix Biosciences, a company dedicated to the application of gene expression profiling during early discovery and pre-clinical drug development trials. John obtained his BS in Computer Sciences and his BS in Biology from California State University, Chico.